Janus Henderson Group PLC Buys 229,718 Shares of Mirion Technologies, Inc. (NYSE:MIR)

Janus Henderson Group PLC increased its holdings in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 2.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,330,495 shares of the company's stock after acquiring an additional 229,718 shares during the period. Janus Henderson Group PLC owned about 3.59% of Mirion Technologies worth $145,367,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Graham Capital Management L.P. bought a new stake in shares of Mirion Technologies in the 4th quarter worth about $1,880,000. Ensign Peak Advisors Inc acquired a new position in Mirion Technologies in the fourth quarter worth $8,240,000. Chescapmanager LLC increased its stake in shares of Mirion Technologies by 27.5% in the fourth quarter. Chescapmanager LLC now owns 1,327,895 shares of the company's stock valued at $23,172,000 after buying an additional 286,494 shares in the last quarter. D. E. Shaw & Co. Inc. acquired a new position in Mirion Technologies during the 4th quarter worth about $5,576,000. Finally, Deutsche Bank AG lifted its position in Mirion Technologies by 82.7% during the 4th quarter. Deutsche Bank AG now owns 311,446 shares of the company's stock worth $5,435,000 after buying an additional 141,008 shares in the last quarter. Institutional investors own 78.51% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on MIR shares. Robert W. Baird dropped their target price on shares of Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating for the company in a research note on Friday, April 4th. B. Riley dropped their target price on shares of Mirion Technologies from $19.00 to $17.00 and set a "buy" rating for the company in a research note on Wednesday, April 16th. Finally, Citigroup dropped their price target on shares of Mirion Technologies from $20.00 to $17.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Mirion Technologies currently has a consensus rating of "Buy" and a consensus price target of $18.75.

Mirion Technologies Trading Up 0.8%

NYSE MIR traded up $0.13 during trading on Friday, reaching $17.24. 1,000,960 shares of the stock traded hands, compared to its average volume of 1,699,223. The firm has a market cap of $4.00 billion, a price-to-earnings ratio of -90.74 and a beta of 0.74. The stock's 50-day moving average price is $14.85 and its 200 day moving average price is $15.82. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43. Mirion Technologies, Inc. has a fifty-two week low of $9.11 and a fifty-two week high of $18.81.

Mirion Technologies (NYSE:MIR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.08 by $0.02. The firm had revenue of $202.00 million during the quarter, compared to analysts' expectations of $199.34 million. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. The business's revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.06 earnings per share. Analysts predict that Mirion Technologies, Inc. will post 0.39 EPS for the current year.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.